About
Non-invasive neurostimulation products
Areas of Focus
Categories
Uncategorized Medical DeviceBiotech
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
2
As Collaborator
4
Total Enrollment
1,576
By Phase
EARLY_PHASE1: 2NA: 1PHASE2/PHASE3: 1PHASE1/PHASE2: 1
By Status
UNKNOWN: 3WITHDRAWN: 1NOT_YET_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06461221Collaborator
tFUS to Enhance Alertness and Performance
EARLY_PHASE1Withdrawn
Started: Aug 1, 2025 · Completed: Aug 1, 2025
NCT06629428Collaborator
Effects of Ublituximab on Motor Functions in Multiple Sclerosis
EARLY_PHASE1Not yet recruiting
25 participants
Started: Oct 1, 2024 · Completed: Dec 31, 2026
NCT05895474Collaborator
Safety Assessment of Central Medial Thalamus Stimulation Using Transcranial Focused Ultrasound
NACompleted
30 participants
Started: May 15, 2023 · Completed: Apr 23, 2025
NCT04447937Lead Sponsor
Immunodeficiency in MS
N/AUnknown
1,500 participants
Started: Jun 29, 2020 · Completed: Jul 30, 2021
NCT02440152Collaborator
The Effectiveness of Deep Brain Stimulation for Opioid Relapse Prevention
PHASE2/PHASE3Unknown
6 participants
Started: Feb 1, 2017 · Completed: Jul 31, 2021
Locations (1)
Headquarters
San Francisco, CA, United States
Map
Loading map...